Massimo Marin

Massimo Marin is the Group Chief Strategy & Corporate Development Officer at Angelini Industries and a member of the Board of Directors of the parent company, Angelini Holding S.p.A.

Massimo has extensive experience in strategic advisory, beginning his career in 2003 at Accenture Management Consulting and EY Financial Business Advisory. In 2007, he joined Bain & Company, where he focused primarily on the Healthcare and Private Equity sectors.

In 2018, he was appointed Global Chief Operating Officer of the Althea Group, and in 2020, he served as Chief Operating Officer at the Fondazione Policlinico Agostino Gemelli, supporting its management during the COVID-19 emergency.

He has completed several advanced executive programs, including the M&A and Corporate Strategy Program (2023) and the International Development Program – BoD Management and Effectiveness (2025) at INSEAD. In 2024, he completed the Executive Breakthrough Program by Egon Zehnder and Mobius Leadership, as well as the Accelerated Program for CFOs at SDA Bocconi School of Management. Since 2025, he has also served as a member of the Investment Advisory Board of LA4G (Luiss Alumni 4 Growth).

In addition to his role as a Board Director and member of the Investment Committee at Angelini Holding, he serves on the Board of Directors and Executive Committee of Fater, a joint venture with P&G. He is also a Board member of several operating companies within Angelini Industries, including Angelini Pharma, Angelini Technologies, Angelini Wines & Estates, Angelini Experiences, and Angelini Real Estate.